Senseonics (NASDAQ:SENS) Upgraded at Raymond James Financial

Raymond James Financial upgraded shares of Senseonics (NASDAQ:SENS) from an underperform rating to a market perform rating in a report released on Tuesday, Marketbeat.com reports.

A number of other research firms also recently commented on SENS. Wall Street Zen upgraded shares of Senseonics from a “strong sell” rating to a “sell” rating in a research note on Saturday, August 8th. Barclays began coverage on Senseonics in a report on Wednesday, October 7th. They issued an “equal weight” rating and a $10.00 price objective for the company. Weiss Ratings raised Senseonics from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, November 4th. Mizuho dropped their target price on Senseonics from $20.00 to $18.00 and set an “outperform” rating on the stock in a report on Wednesday, July 15th. Finally, TD Cowen reiterated a “buy” rating and set a $15.00 target price on shares of Senseonics in a report on Tuesday, October 27th. Three research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $14.40.

Senseonics Stock Performance

Shares of SENS opened at $10.04 on Tuesday. Senseonics has a 12 month low of $4.79 and a 12 month high of $13.98. The firm has a fifty day simple moving average of $9.16 and a 200 day simple moving average of $7.31. The company has a debt-to-equity ratio of 0.70, a quick ratio of 6.40 and a current ratio of 5.92.

Senseonics (NASDAQ:SENS) last issued its quarterly earnings results on Monday, November 9th. The company reported ($0.50) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.49) by ($0.01). Senseonics had a negative net margin of 204.01% and a negative return on equity of 186.11%. The business had revenue of $19.56 million during the quarter. As a group, equities analysts expect that Senseonics will post -2.30 earnings per share for the current fiscal year.

Insider Buying and Selling at Senseonics

In other news, Director Douglas Roeder bought 13,953 shares of the firm’s stock in a transaction that occurred on Wednesday, August 19th. The stock was acquired at an average cost of $8.98 per share, with a total value of $125,297.94. Following the completion of the purchase, the director owned 171,191 shares of the company’s stock, valued at $1,537,295.18. This represents a 8.87% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 4.70% of the company’s stock.

Institutional Trading of Senseonics

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Ieq Capital LLC bought a new position in shares of Senseonics in the 3rd quarter valued at about $215,000. StoneX Group Inc. acquired a new position in shares of Senseonics during the 3rd quarter worth about $128,000. Traynor Capital Management Inc. acquired a new position in shares of Senseonics during the 3rd quarter worth about $152,000. State of Wyoming increased its stake in shares of Senseonics by 27.2% during the 3rd quarter. State of Wyoming now owns 14,940 shares of the company’s stock worth $152,000 after purchasing an additional 3,199 shares during the last quarter. Finally, Integrated Wealth Concepts LLC bought a new stake in shares of Senseonics in the 2nd quarter valued at about $36,000. 12.36% of the stock is owned by institutional investors.

Recent Senseonics Headlines

These are some of the SENS headlines that stood out recently:

• Positive Sentiment: HC Wainwright reaffirmed its Buy rating and $14 price target. It also raised its FY2026 estimate and improved its forecasts for FY2028–FY2030, suggesting a more favorable longer-term earnings trajectory. HC Wainwright rating reaffirmed
• Positive Sentiment: Other analyst headlines cite strong price-appreciation outlooks from Mizuho and Barclays, and a TD Cowen price-target increase. Mizuho forecast Barclays forecast TD Cowen target
• Neutral Sentiment: Analyst opinions are not uniformly bullish: Stifel Nicolaus assigned a Hold rating, while Raymond James upgraded SENS to Market Perform. Stifel rating Raymond James rating

Senseonics Company Profile

Senseonics Holdings, Inc. develops continuous glucose monitoring (CGM) technology for people with diabetes. Its Eversense systems use a small sensor implanted under the skin to measure glucose levels, an external wearable transmitter to send readings, and a mobile app to display data and provide alerts. The company’s product line includes implantable CGM systems designed for extended wear, including the Eversense 365 system, which is designed to last up to one year. Unlike many CGM products that use sensors replaced more frequently, Eversense sensors are inserted and removed by a healthcare professional.